YD Bio Limited Ordinary Shares (YDES) Earnings History
Net Loss5 years of earnings data (2020–2024) · Currently unprofitable on a TTM basis
Loading earnings history...
YD Bio Limited Ordinary Shares (YDES) Earnings Overview
As of June 28, 2026, YD Bio Limited Ordinary Shares (YDES) reported trailing twelve-month net income of -$3M. The company earned $-0.87 per diluted share over the past four quarters, with a net profit margin of -276.6%.
Looking at the long-term picture, YDES's historical earnings data spans multiple years. The company achieved its highest annual net income of $9M in fiscal 2021.
YD Bio Limited Ordinary Shares is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including BTBT (-$169M net income, -70.7% margin), NUVB (-$146M net income, -325.3% margin), ZLAB (-$178M net income, -38.1% margin), YDES has room to improve margins relative to the peer group. Compare YDES vs BTBT →
YDES Earnings vs Peers
Earnings metrics vs comparable public companies
YDES Historical Earnings Data (2020–2024)
5 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2024 | -$1M | -10509.7% | -$1M | $-0.56 | -276.6% | -286.5% |
| 2023 | $13,560 | -99.6% | $-9,847 | $0.00 | 3.9% | -2.8% |
| 2022 | $4M | -56.5% | -$2M | $0.41 | - | - |
| 2021 | $9M | +443.0% | -$2M | $0.59 | - | - |
| 2020 | -$3M | - | $-344,223 | $-0.17 | - | - |
Download Data
Export YDES earnings history in CSV or JSON format
Free sign-in required to download data
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
6+ years return with dividends reinvested.
DCA Calculator
See how regular investing compounds over time.
Peer Comparison
Compare growth, multiples, and margins vs sector.
YDES — Frequently Asked Questions
Quick answers to the most common questions about buying YDES stock.
What is YDES earnings per share (EPS)?
YDES trailing twelve-month (TTM) diluted EPS is $-0.87, reflecting N/A year-over-year growth. The 5-year EPS CAGR is N/A. Complete EPS history from 2020 to 2024 is available in the table on this page.
What is YD Bio Limited Ordinary Shares's net income?
YD Bio Limited Ordinary Shares (YDES) trailing twelve-month net income is $-3M as of 2024. Earnings declined N/A year-over-year.
Is YDES profitable?
YDES is not currently profitable on a TTM basis, reporting a net loss of $-3M. Net margin is -276.6%. Investors should monitor for a return to profitability.
What is YDES's earnings growth rate?
YDES compound annual EPS growth rates (CAGR): 1-Year: N/A, 3-Year: N/A, 5-Year: N/A, 10-Year: N/A. These figures measure the annualised rate of diluted EPS growth over each period, based on data from 2020 to 2024.
What are YDES's profit margins?
YD Bio Limited Ordinary Shares net profit margin is -276.6%, operating margin is -286.5%, and gross margin is +30.4%. Below-average margins reflect competitive or cost pressures. Return on Equity is -42.7%.
Is YDES growing earnings?
YDES TTM EPS: $-0.87. Net income: $-3M. YoY earnings change: N/A.
What was YDES's best earnings year?
YD Bio Limited Ordinary Shares's highest annual net income on record is $9M, achieved in fiscal year 2021. Earnings history on this page spans 2020 to 2024 and includes all annual and quarterly figures.
What were YDES's earnings last quarter?
YDES's most recent reported quarter was Q2 2025. Net income was $-2M with diluted EPS of $-0.65. For a full breakdown of all quarters, see the quarterly earnings table on this page.